Clinical trial
Benefits of Medical Therapy Plus Stenting for Renal Atherosclerotic Lesions
NCT00081731 · Baim Institute for Clinical Research, Other · Completed
Key facts
| NCT number | NCT00081731 |
|---|---|
| Title | Benefits of Medical Therapy Plus Stenting for Renal Atherosclerotic Lesions |
| Official title | Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL) |
| Acronym | CORAL |
| Lead sponsor | Baim Institute for Clinical Research, Other |
| Collaborators | Beth Israel Deaconess Medical Center |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Atherosclerosis, Cardiovascular Diseases, Hypertension, Renovascular, Renal Artery Obstruction |
| Intervention type | Drug, Procedure |
| Interventions | Atacand/HCT, Caduet, GENESISTM Embolic Protection Stent and Angioguard Device (Angioplasty plus stenting) |
| Enrollment | 947 |
| Start date | Apr 1, 2004 |
| Primary completion | Sep 1, 2013 |
| Completion | Sep 1, 2013 |
| First posted | Apr 21, 2004 |
| Last update posted | Oct 5, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: